Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1
Open Access
- 27 May 2004
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (14), 1170-1174
- https://doi.org/10.1038/sj.gt.3302269
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Efficient Lentiviral Vectors for Short Hairpin RNA Delivery into Human CellsHuman Gene Therapy, 2003
- RNA interferenceNature, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Overexpression of Cytochrome P450 CYP2J2 Protects against Hypoxia-Reoxygenation Injury in Cultured Bovine Aortic Endothelial CellsMolecular Pharmacology, 2001
- The orphan nuclear receptor SXR coordinately regulates drug metabolism and effluxNature Medicine, 2001
- RNA interference is mediated by 21- and 22-nucleotide RNAsGenes & Development, 2001
- Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoterGene Therapy, 2000
- Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activationProceedings of the National Academy of Sciences, 2000
- Retrovirus-Mediated Transfer of Anti-MDR1 Ribozymes Fully Restores Chemosensitivity of P-Glycoprotein-Expressing Human Lymphoma CellsHuman Gene Therapy, 1999